1 / 39

THYROID DISORDERS

THYROID DISORDERS. Abdelaziz Elamin. MD, PhD, FRCPCH Professor of Child Health Consultant Pediatric Endocrinologist Sultan Qaboos University, Oman. HYPOTHYROIDISM-EPIDEMIOLOGY. Neonatal screening reveals incidence that varies between 1-5/1000 live births

Pat_Xavi
Download Presentation

THYROID DISORDERS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. THYROID DISORDERS Abdelaziz Elamin. MD, PhD, FRCPCH Professor of Child Health Consultant Pediatric Endocrinologist Sultan Qaboos University, Oman

  2. HYPOTHYROIDISM-EPIDEMIOLOGY • Neonatal screening reveals incidence that varies between 1-5/1000 live births • The most common cause of preventable mental retardation in children • Both acquired & congenital forms are linked to iodine deficiency • Diagnosis is easy & early treatment is beneficial

  3. ETIOLOGY • CONGENITAL • Hypoplasia & mal-descent • Familial enzyme defects • Iodine deficiency (endemic cretinism) • Intake of goitrogens during pregnancy • Pituitary defects • Idiopathic

  4. ETIOLOGY /2 • ACQUIRED • Iodine deficiency • Auto-immune thyroiditis • Thyroidectomy or RAI therapy • TSH or TRH deficiency • Medications (iodide & Cobalt) • Idiopathic

  5. KILPATRIK GRADING OF GOITRE • Grade 0: Not visible neck extended & Not palpable • Grade 1: Not visible, but palpable • Grade 2: Visible only when neck is extended & on swallowing, • Grade 3: Visible in all positions • Grade 4: Large goiter

  6. THYROID GLAND • Derived from pharyngeal endoderm at 4/40 • Migrate from base of the tongue to cover the 2&3 tracheal rings. • Blood supply from ext. carotid & subclavian and blood flow is twice renal blood flow/g tissue. • Starts producing thyroxin at 14/40.

  7. OVERVIEW (2) • Maternal & fetal glands are independent with little transplacental transfer of T4. • TSH doesn’t cross the placenta. • Fetal brain converts T4 to T3 efficiently. • Average intake of iodine is 500 mg/day. 70% of this is trapped by the gland against a concentration gradient up to 600:1

  8. THYROID HORMONES • Iodine & tyrosine form both T3 & T4 under TSH stimulation. However, 10% of T4 production is autonomous and is present in patients with central hypothyroidism. • When released into circulation T4 binds to: • Globulin TBG 75% • Prealbumin TBPA 20% • Albumin TBA 5%

  9. THYROID HORMONES (2) • Less than 1% of T4 & T3 is free in plasma. • T4 is deiodinated in the tissues to either T3 (active) or reverse T3 (inactive). • At birth T4 level approximates maternal level but increases rapidly during the first week of life. • High TSH in the first 5 days of life can give false positive neonatal screening

  10. TSH • Is a Glico-protein with Molecular Wt of 28000 • Secreted by the anterior pituitary under influence of TRH • It stimulates iodine trapping, oxidation, organification, coupling and proteolysis of T4 & T3 • It also has trophic effect on thyroid gland

  11. TSH (2) • T4 & T3 are feed-back regulators of TSH • TSH is stimulated by a-adrenergic agonists • TSH secretion is inhibited by: • Dopamine • Bromocreptine • Somatostatin • Corticosteroids

  12. THYROID HORMONES (3) • Conversion of T4 to T3 is decreased by: • Acute & chronic illnesses • b-adrenergic receptor blockers • Starvation & severe PEM • Corticosteroids • Propylthiouracil • High iodine intake (Wolff-Chaikoff effect)

  13. THYROXINE (T4) • Total T4 level is decreased in: • Premature infants • Hypopituitarism • Nephrotic syndrome • Liver cirrhosis • PEM • Protein losing entropathy

  14. THYROXINE (2) • Total T4 is decreased when the following drugs are used: • Steroids • Phenytoin • Salicylates • Sulfonamides • Testosterone • Maternal TBII

  15. THYROXINE (3) • Total T4 is increased with: • Acute thyroiditis • Acute hepatitis • Estrogen therapy • Clofibrate • iodides • Pregnancy • Maternal TSI

  16. FUNCTIONS OF THYROXINE • Thyroid hormones are essential for: • Linear growth & pubertal development • Normal brain development & function • Energy production • Calcium mobilization from bone • Increasing sensitivity of b-adrenergic receptors to catecholeamines

  17. CLINICAL FEATURES • Gestational age > 42 weeks • Birth weight > 4 kg • Open posterior fontanel • Nasal stuffiness & discharge • Macroglossia • Constipation & abdominal distension • Feeding problems & vomiting

  18. CLINICAL FEATURES (2) • Non pitting edema of lower limbs & feet • Coarse features • Umbilical hernia • Hoarseness of voice • Anemia • Decreased physical activity • Prolonged (>2/52) neonatal jaundice

  19. CLINICAL FEATURES (3) • Dry, pale & mottled skin • Low hair line & dry, scanty hair • Hypothermia & peripheral cyanosis • Hypercarotenemia • Growth failure • Retarded bone age • Stumpy fingers & broad hands

  20. CLINICAL FEATURES (5) • Skeletal abnormalities: • Infantile proportions • Hip & knee flexion • Exaggerated lumbar lordosis • Delayed teeth eruption • Under developed mandible • Delayed closure of anterior fontanel

  21. OCCASIONAL FEATURES • Overt obesity • Myopathy & rheumatic pains • Speech disorder • Impaired night vision • Sleep apnea (central & obstructive) • Anasarca • Achlorhydria & low intrinsic factor

  22. OCCASIONAL FEATURES (2) • Decreased bone turnover • Decreased VIII, IX & platelets adhesion • Decreased GFR & hyponatremia • Hypertension • Increased levels of CK, LDH & AST • Abnormal EEG & high CSF protein • Psychiatric manifestations

  23. ASSOCIATIONS • Autoimmune diseases (Diabetes Mellitus) • Cardiomyopathy & CHD • Galactorrhoea • Muscular dystrophy + pseudohypertrophy (Kocher-Debre-Semelaigne)

  24. GOITROGENS • DRUGS • Anti-thyroid • Cough medicines • Sulfonamides • Lithium • Phenylbutazone • PAS • Oral hypoglycemic agents

  25. GOITROGENS • FOOD • Soybeans • Millet • Cassava • Cabbage

  26. CLINICAL FEATURES (4) • Neurological manifestations • Hypotonia & later spasticity • Lethargy • Ataxia • Deafness + Mutism • Mental retardation • Slow relaxation of deep tendon jerks

  27. CONGENITAL HYPOTHYRODISM • Primary thyroid defect: usually associated with goiter. • Secondary to hypothalamic or pituitary lesions: not associated with goiter. • 2 distinct types of presentation: • Neurological with MR-deafness & ataxia • Myxodematous with dwarfism & dysmorphism

  28. DIAGNOSIS • Early detection by neonatal screening • High index of suspicion in all infants with increased risk • Overt clinical presentation • Confirm diagnosis by appropriate lab and radiological tests

  29. LABROTARY FINDINGS • Low (T4, RI uptake & T3 resin uptake) • High TSH in primary hypothyroidism • High serum cholesterol & carotene levels • Anaemia (normo, micro or macrocytic) • High urinary creatinine/hydroxyproline ratio • CXR: cardiomegaly • ECG: low voltage & bradycardia

  30. IMAGING TESTS • X-ray films can show: • Delayed bone age or epiphyseal dysgenesis • Anterior peaking of vertebrae • Coxavara & coxa plana • Thyroid radio-isotope scan • Thyroid ultrasound • CT or MRI

  31. TREATMENT (2) • L-Thyroxin is the drug of choice. Start with small dose to avoid cardiac strain. • Dose is 10 mg/kg/day in infancy. In older children start with 25 mg/day and increase by 25 mg every 2 weeks till required dose. • Monitor clinical progress & hormones level

  32. TREATMENT • Life-long replacement therapy • 5 types of preparations are available: • L-thyroxin (T4) • Triiodothyronine (T3) • Synthetic mixture T4/T3 in 4:1 ratio • Desiccated thyroid (38mg T4 & 9mg T3/grain) • Thyroglobulin (36mg T4 & 12mg T3/grain)

  33. THYROID FUNCTION TESTS 1.Peripheral effects: • BMR • Deep Tendon Reflex • Cardiovascular indices (pulse, BP, LV function tests) • Serum parameters (high cholesterol, CK, AST, LDH & carcino-embryonic antigen)

  34. THYROID FUNCTION TESTS (2) 2. Thyroid gland economy: • Radio iodine uptake • Perchlorate discharge test (+ve in Pendred syndrome & autoimmune thyroiditis) • TSH level • TRH stimulation tests • Thyroid scan

  35. THYROID FUNCTION TESTS (3) 3. Tests for thyroid hormone: • Total & free T4 & T3 • Reverse T3 level • T3 Resin Uptake • T3RU x total T4= Thyroid Hormone Binding Index (formerly Free Thyroxin Index)

  36. THYROID FUNCTION TESTS (4) • Special Tests: • Thyroglobulin level • Thyroid Stimulating Immunoglobulin • Thyroid antibodies • Thyroid radio-isotope scan • Thyroid ultrasound • CT & MRI • Thyroid biopsy

  37. PROGNOSIS • Depends on: • Early diagnosis • Proper diabetes education • Strict diabetic control • Careful monitoring • Compliance

  38. MYXOEDMATOUS COMA • Impaired sensorium, hypoventilation bradycardia, hypotension & hypothermia • Precipitated by: • Infections • Trauma (including surgery) • Exposure to cold • Cardio-vascular problems • Drugs

  39. PROGNOSIS • Is good for linear growth & physical features even if treatment is delayed, but for mental and intellectual development early treatment is crucial. • Sometimes early treatment may fail to prevent mental subnormality due to severe intra-uterine deficiency of thyroid hormones

More Related